secwatch.observer — SEC 8-K summary
======================================

Issuer:     Apyx Medical Corp (APYX)
CIK:        0000719135
Form:       8-K
Filed at:   2025-05-13T23:59:59+00:00
Accession:  0001437749-25-016259
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Apyx Medical receives FDA 510(k) clearance for AYON Body Contouring System
--------------------------------------------------------------------------

- AYON is the first FDA-cleared all-in-one platform combining fat removal, contouring, tissue contraction, and electrosurgery.
- Initial clearance covers Renuvion for lax skin, ultrasound liposuction, electrocoagulation; power liposuction submission planned later in 2025.
- Commercial launch with key opinion leader surgeons in critical geographies expected in second half of 2025.
- Company highlights >15 million GLP-1 drug users as a growth driver for body contouring procedures.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/719135/000143774925016259/0001437749-25-016259-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/719135/000143774925016259/apyx20250509_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-016259

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer